Maravai LifeSciences (NASDAQ:MRVI) Hits New 12-Month Low Following Analyst Downgrade
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00. Bank of America currently has a buy rating on the stock. Maravai LifeSciences traded as low as $2.92 and last traded at […]
